T1	Participants 904 1039	23 patients died, 15 were lost to follow-up, 45 refused repeat colonoscopy, and five developed severe contraindications to colonoscopy.
T2	Participants 1050 1134	552 participants who completed the follow-up examination, 94 stopped treatment early
T3	Participants 546 754	665 patients with a history of colorectal adenomas to three treatment groups, in a parallel design: calcium gluconolactate and carbonate (2 g elemental calcium daily), fibre (3.5 g ispaghula husk), or placebo
